Dr. Prof Suresh H. Advani, Dr. Suresh Hariram Advani
Senior Consultant
55 Years of ExperienceMedical Oncologist
MBBS, MD, FICP, MNAMS, FNAMS, Fellowship, DM
Reg. No.:25840 Maharashtra Medical Council, 1970
Nanavati Super Specialty Hospital, Mumbai
English, Hindi
About Dr. Prof Suresh H Advani
Dr. Suresh Hariram Advani, born August 1, 1947, is a globally recognized Medical Oncologist who revolutionized cancer care in India. He completed his MBBS (1966) and MD in General Medicine from Grant Medical College, Mumbai, followed by specialized training in Internal Medicine, Hematology, and Oncology at JJ Hospital and Grant Medical College. His transformative international training included a fellowship at the Fred Hutchinson Cancer Research Center in Seattle, Washington, where he trained under Nobel laureate Dr. E. Donnall Thomas, the pioneer of bone marrow transplantation in the United States.
Dr. Suresh H. Advani served as Chief of the Cancer Department at Tata Memorial Hospital from 1974, where he spent several decades advancing cancer treatment protocols and establishing bone marrow transplantation infrastructure in India. Over the course of his five-decade career, he has served as a consultant and senior consultant at multiple prestigious institutions, including Nanavati Hospital, Apollo Hospitals, Hiranandani Hospital, and Reliance Hospital. He has treated over 2 million cancer patients from across India and globally, utilizing the latest advanced oncology medicines and treatment modalities available worldwide.
Dr. Suresh H. Advani's Expertise and Specializations
- Bone Marrow & Stem Cell Transplantation: Dr. Suresh H. Advani is credited as India's pioneer in establishing bone marrow transplantation, performing the country's first successful transplant, and revolutionizing cancer care in India. As a top Cancer Doctor in Mumbai, he specializes in both autologous and allogeneic stem cell transplantation for blood cancers, multiple myeloma, lymphomas, and leukemias, offering patients access to cutting-edge hematopoietic stem cell transplant technology. Dr. Advani's expertise in bone marrow transplantation remains unparalleled among oncologists in Mumbai.
- Hematologic Malignancies Management: With exceptional expertise in treating blood cancers, Dr. Suresh H. Advani, the best Oncologist in Mumbai, specializes in acute leukemias, chronic myeloid leukemia, lymphomas (including Hodgkin's and non-Hodgkin's lymphomas), and multiple myeloma. His comprehensive approach encompasses chemotherapy, targeted therapy, and immunotherapy, all tailored to each patient's unique molecular profile, ensuring personalized cancer treatment for every case.
- Solid Tumor Oncology: Dr. Suresh H. Advani, at Nanavati Hospital, offers expert management of various solid tumors, including breast cancer, cervical cancer, lung cancer, gastric cancer, and head and neck cancers, utilizing multimodal treatment approaches that combine surgery, chemotherapy, and radiation. As a leading Nanavati Cancer Specialist, Dr. Advani brings decades of experience to complex solid tumor cases.
- Targeted Therapy & Biological Therapeutics: With a special interest in developmental therapeutics and biological therapeutics that target molecular pathways in cancer cells, Dr. Suresh H. Advani, Medical Oncologist, provides personalized cancer treatment based on tumor genetics and molecular profiling, ensuring optimal outcomes. His expertise in targeted molecular therapy positions him among the top cancer doctors in Mumbai for advanced treatment options.
- Immunotherapy & Advanced Cancer Treatment: Dr. Suresh H. Advani is proficient in administering the latest immunotherapy, targeted drugs, and biologics available globally for cancer management. His commitment to utilizing cutting-edge treatments ensures patients receive the most advanced and effective cancer care available internationally.
Ask anything about your health.
Get trusted answers directly from our Medical Experts
Top Procedures Performed by Dr. Suresh H. Advani and Their Cost
Dr. Suresh H. Advani offers advanced cancer treatment procedures utilizing the latest international standards and technology. Below is an overview of key procedures along with estimated costs:
|
Procedure |
Cost in INR |
Cost in USD |
|
Autologous Bone Marrow/Stem Cell Transplant |
INR 15,00,000 - INR 25,00,000 |
USD 18,000 – USD 30,000 |
|
Allogeneic Bone Marrow/Stem Cell Transplant |
INR 20,00,000 - INR 30,00,000 |
USD 24,000 – USD 36,000 |
|
Comprehensive Cancer Chemotherapy Protocol (per cycle) |
INR 50,000 - INR 2,00,000 |
USD 600 – USD 2,400 |
|
Targeted Therapy Treatment (monthly) |
INR 80,000 - INR 5,00,000 |
USD 950 – USD 6,000 |
|
Immunotherapy Administration (per infusion) |
INR 1,00,000 - INR 4,00,000 |
USD 1,200 – USD 4,800 |
|
Advanced Molecular Profiling & Genetic Testing |
INR 30,000 - INR 1,00,000 |
USD 365 – USD 1,200 |
Note: The costs mentioned are approximate and may vary based on case complexity, treatment protocol, hospital-specific policies, patient condition, and current drug availability. Consultation with Dr. Advani's team is recommended for precise cost estimates.
Some Noteworthy Patient Reviews for Dr. Suresh H. Advani
Dr. Suresh H. Advani is highly regarded for his exceptional clinical expertise, compassionate patient care, and pioneering spirit in the field of oncology. Here are testimonials from his patients highlighting their experiences with this top cancer doctor in Mumbai:
"Dr. Suresh H. Advani's guidance and treatment at Nanavati Hospital finally made me cancer-free. He is such an amazing doctor with a happy soul. His expertise and dedication are unmatched. I can go on and on about his exceptional care."
"Dr. Advani's comprehensive approach to my cancer treatment gave me confidence and hope. His knowledge of the latest treatment options, combined with his ability to explain complex medical information in simple terms, made the journey manageable. Scheduling an appointment with Dr. Suresh H. Advani was straightforward, and his consultation fees were transparent."
"As a medical professional myself, I was impressed by Dr. Suresh H. Advani, Medical Oncologist, 's depth of knowledge and his commitment to personalized treatment. He listened to my concerns and tailored the treatment plan specifically for my condition, demonstrating why he is recognized as the best oncologist in Mumbai."
"Dr. Advani's team was professional, supportive, and compassionate throughout my treatment at Nanavati Max Institute of Cancer Care. The combination of clinical excellence and emotional support made all the difference in my recovery. Getting Dr. Suresh H. Advani's contact number and scheduling an appointment was seamless."
MediJourney is dedicated to simplifying your healthcare process by coordinating your appointment with Dr. Suresh H. Advani at Nanavati Hospital. Our experienced medical coordinators will manage all booking details, confirm your preferred date and time, and provide comprehensive information about consultation fees and hospital logistics. To inquire about Dr. Suresh H. Advani's consultation fees, schedule an appointment, or obtain his contact information, please contact MediJourney to discuss your treatment options with India's leading oncologist.
OPD Schedule Of Dr. Prof Suresh H Advani
Consultation Fees Rs. N/A /-
Sir HN Reliance Foundation Hospital & Research Centre, Mumbai
Book Your Appointment With Dr. Prof Suresh H Advani
Get a Treatment Plan Within 1 Hour
Education
- MBBS - University of Bombay, 1970
- MD (General Medicine) – Grant Medical College, Mumbai (Post-Graduation)
- DM (Oncology) – Specialized Doctorate in Medical Oncology
Training & Certificates
- Fellowship in Bone Marrow Transplantation – Fred Hutchinson Cancer Research Center, Seattle, Washington, USA (trained under Nobel laureate Dr. E. Donnall Thomas)
- International Cancer Research Technology Transfer (ICRETT) Fellowship – International Union Against Cancer, 1981 (4 weeks at Fred Hutchinson Cancer Research Centre, Seattle)
- Fellowship of Yamagiwa-Yoshida Memorial International Cancer Study Grant – International Union Against Cancer (UICC), 1986
- Certifications: FICP (Fellow of the Indian College of Physicians), FNAMS (Fellow of the National Academy of Medical Sciences), MNAMS (Member of the National Academy of Medical Sciences)
Past Experience
- Chief of Cancer Department – Tata Memorial Hospital, Mumbai (1974 - several decades)
- Senior Consultant, Medical Oncology – Nanavati Max Institute of Cancer Care, Mumbai (current)
- Consultant & Senior Consultant – Apollo Hospitals, CBD Belapur, Mumbai
- Consultant Medical Oncologist – Hiranandani Hospital, Mumbai
- Consultant Medical Oncologist – Reliance Hospital, Mumbai
- Consultant – Tata Memorial Hospital, Mumbai
Awards
- Padma Bhushan – Government of India (2012) – Highest civilian honor for exceptional service to the nation
- Padma Shri – Government of India (2002) – Distinguished service to medicine and scientific research
- Rashtriya Krantiveer Award (2014) – For outstanding contributions to medical science
- Lifetime Achievement in Oncology Award – Harvard Medical International Institute (2005) – Recognizing pioneering contributions to cancer care
- Dhanvantari Award – For outstanding contributions to medicine (2002)
- Pharma Leaders Indian of the Year – Oncology – (2018) – Recognition for leadership in pharmaceutical oncology
- Dr. Tank Best Paper Award – Mumbai
- Dr. BC Roy National Award by the Medical Council of India - 2005
Associations/Membership
- Fellow of the Indian College of Physicians (FICP)
- Fellow of the National Academy of Medical Sciences (FNAMS)
- Member of the National Academy of Medical Sciences (MNAMS)
- International Union Against Cancer (UICC)
- Indian Medical Association (IMA)
Paper Published
Dr. Suresh H. Advani has authored and co-authored over 650 national and international publications in peer-reviewed journals and medical literature, focusing on oncology, bone marrow transplantation, hematologic malignancies, and cancer therapeutics.
- "Alterations in electrophoretic mobility of mouse macrophage treated with microtubule inhibitors" – AN Bhisey, SGA Rao & SH Advani. Indian Journal of Experimental Biology, 15: 970-972, 1972.
- "Studies on I, I and IT antigens in lymphoma Hodgkin's disease and multiple myeloma" – SR Joshi, SH Advani, HM Bhatia. Indian Journal of Medical Research, 72: 715-720, 1980.
- "Management of squamous cell carcinoma" – Shripad Banavali, Bishan Charak, and Suresh Advani. Indian Journal of Medical Research, 92: 83-85, 1990
Field of Expertise
- Adrenal Cancer Treatment
- Bacillus Calmette Guerin (BCG) Therapy
- Benign and Cancerous Tumor Excision
- Bile Duct Cancer Treatment
- Bone Marrow Transplant
- Brachytherapy Treatment
- Brain Tumor Surgery
- Breast Biopsy
- Breast Cancer Treatment
- Cancer Treatment
- CAR T-Cell Therapy
- Carcinoid Tumor Treatment
- Castleman Disease Treatment
- Cervical Cancer Treatment
- Chemotherapy
- Colon Cancer Surgery
- Colorectal Cancer Treatment
- Completion Thyroidectomy
- CyberKnife Surgery
- Endometrial Cancer Treatment
- Endoscopic Tumor Removal
- Ewing Family of Tumors Treatment
- Fine Needle Aspiration
- Gallbladder Cancer Treatment
- Genitourinary Cancer Treatment
- Gestational Trophoblastic Disease (GTD) Treatment
- High-Intensity Focused Ultrasound (HIFU) for Prostate Cancer
- Hormone Therapy
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
- Image-Guided Radiation Therapy (IGRT)
- Immunotherapy
- Intensity-Modulated Radiation Therapy (IMRT)
- Kaposi Sarcoma Treatment
- Liver Cancer Treatment
- Lumpectomy
- Lung Cancer Treatment
- Malignant Mesothelioma Treatment
- Metastatic Tumor Treatment
- Minimally Invasive Cancer Surgery
- Nasal Cavity and Paranasal Sinus Cancer Treatment
- Nasopharyngeal Cancer Treatment
- Non-Small Cell Lung Cancer (NSCLC) Treatment
- Oncological Surgery
- Ovarian Cancer Treatment
- Papillary Thyroid Cancer Treatment
- Penile Cancer Treatment
- PET CT Scan
- Proton Therapy
- Radiation Therapy
- Radioisotope Therapy
- Rhabdomyosarcoma (RMS) Treatment
- Robotic Cancer Surgery
- Skin Lymphoma Treatment
- Small Intestine Cancer Treatment
- Stomach Cancer Treatment
- Targeted Therapy
- Thymectomy
- Thymoma and Thymic Carcinoma Treatment
- Thyroid Cancer Treatment
- Transarterial Chemoembolization (TACE)
- Vaginal Cancer Treatment
- Vulvar Cancer Treatment
- Whipple Procedure
- Acute Lymphoblastic Leukemia (ALL)
- Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia (AML)
- Acute Promyelocytic Leukemia (APL)
- Adenocarcinoma
- Adenosquamous Carcinoma
- Adrenocortical Carcinoma
- Adult Hodgkins Lymphoma
- AIDS-Related Cancer
- Ameloblastoma
- Anal Cancer
- Anaplastic Carcinoma
- Appendix Cancer
- Atypical Hyperplasia
- Atypical Spindle Cell Tumor
- Atypical Teratoid/Rhabdoid Tumor (ATRT)
- Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
- Basal Cell Carcinoma (BCC)
- Basal Cell Carcinoma of the Skin
- Benign Bone Tumors
- Benign Hematology
- Benign Lung Tumors
- Benign Soft Tissue Tumors
- Bile Duct Cancer, Stones, & Strictures
- Bladder Cancer
- Blood Cancer
- Bone Cancer
- Bone Marrow Cancer
- Breast Cancer
- Breast Cancer During Pregnancy
- Breast Cancer Recurrence
- Bronchial Tumors
- Burkitt Lymphoma
- Cancer in Children
- Carcinoid Syndrome
- Carcinoid Tumor (Gastrointestinal)
- Carcinoid Tumors of the Lungs
- Cervical Cancer
- Childhood Acute Lymphoblastic Leukemia
- Cholangiocarcinoma
- Chronic Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia
- Chronic Myeloid Leukemia (CML)
- Chronic Myeloproliferative Neoplasms
- Colorectal Cancer
- Cutaneous T-Cell Lymphoma
- Cyclic Neutropenia
- Desmoid Tumor
- Ductal Carcinoma in Situ (DCIS)
- Elevated PSA (Prostate-Specific Antigen) Level
- Embryonal Tumors
- Eosinophilia
- Esophageal Cancer
- Esophagectomy
- Esthesioneuroblastoma
- Estrogen Dependent Cancers
- Ewing Sarcoma
- Extracranial Germ Cell Tumor
- Extragonadal Germ Cell Tumor
- Extrahepatic Bile Duct Cancer
- Fallopian Tube Cancer
- Familial Adenomatous Polyposis (FAP)
- Familial Adenomatous Polyposis (FAP): Inherited
- Follicular Lymphoma
- Free Flap Surgery for Treating Osteoradionecrosis
- Gallbladder Cancer
- Gastric Cancer
- Gastrointestinal Stromal Tumor (GIST)
- Gestational Trophoblastic Disease
- Giant Cell Tumor
- Gum Tumor
- Hairy Cell Leukemia (HCL)
- Head and Neck Cancer
- Heart Cancer
- Hepatocellular Cancer
- Hereditary Non-polyposis Colorectal Cancer (HNPCC)
- Hurthle Cell Carcinoma
- Hypopharyngeal Cancer
- Hypopharyngeal Cancer
- Immunotherapy
- In-situ Breast Cancer
- Incontinence After Prostate Surgery
- Inflammatory Breast Cancer
- Intensity Modulated Radiation Therapy
- Intraocular Melanoma
- Invasive Breast Cancer
- Invasive Lobular Carcinoma
- Islet Cell Tumor
- Kaposi Sarcoma
- Large Cell Carcinoma
- Large Granular Lymphocytic (LGL) leukemia
- Leukemia
- Lip and Oral Cavity Cancer
- Liver Cancer
- Liver Cysts & Liver Tumors
- Lung Cancer
- Lymphatic Cancer
- Lymphocytosis
- Male Breast Cancer
- Malignant Fibrous Histiocytoma (MFH)
- Malignant Mesothelioma
- Malignant Soft Tissue Tumors
- Mediastinal Tumor
- Medullary Carcinoma
- Melanoma
- Merkel Cell Carcinoma
- Metastatic Cancer
- Metastatic Spinal Tumors
- Metastatic Squamous Neck Cancer with Occult Primary
- Metastatic Tumors
- Mouth Cancer
- Multiple Endocrine Neoplasia (MEN) Syndromes
- Multiple Myeloma
- Myelodysplastic Syndromes
- Nasal Cavity and Paranasal Sinus Cancer
- Nasopharyngeal Cancer
- Neuroendocrine Tumor
- Non-Small Cell Lung Cancer
- NUT Midline Carcinoma
- Oncogenic Osteomalacia
- Ophthalmic Cancer
- Oral Cancer
- Oropharyngeal Cancer
- Osteosarcoma
- Ovarian Cancer
- Ovarian Germ Cell Tumors
- Ovarian Primary Peritoneal Cancer
- Ovarian Sex Cord Stromal Tumor
- Pancreatic Cancer
- Pancreatic Neuroendocrine Tumor
- Paraganglioma
- Paraneoplastic Syndromes
- Parathyroid Cancer
- Parotid Gland Tumor
- Pediatric Chordomas
- Pediatric Ependymoma
- Pediatric Germ Cell Tumor
- Pediatric Rhabdomyosarcoma
- Pediatric Spinal Cord Tumor
- Pediatric Spinal Tumor
- Pediatric Vascular Tumors
- Penile Cancer
- Pharyngeal Cancer
- Pheochromocytoma
- Pigmented Villonodular Synovitis (PVNS)
- Pineal Region Tumor
- Plasma Cell Neoplasms
- Pleural Tumor
- Pleuropulmonary Blastoma
- Prostate Cancer
- PTEN Hamartoma Tumor Syndrome (Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome)
- Pulmonary Nodules
- Pure Red Cell Aplasia (PRCA)
- Rectal Cancer
- Recurrent Cancer
- Relapsed ALL
- Relapsed AML
- Relapsed Multiple Myeloma
- Renal Cell Cancer
- Retinoblastoma (Cancer of the Eye)
- Retroperitoneal Tumor
- Rhabdomyosarcoma
- Salivary Gland Cancer
- Sarcoma
- Sezary Syndrome
- Skin Cancer
- Skull Base Tumor
- Small Cell Carcinoma
- Small Cell Lung Cancer
- Small Intestine Cancer
- Soft Tissue Sarcoma
- Spinal Tumor
- Squamous Cell Carcinoma (SCC)
- Stage 4 Cancer
- Stomach Cancer
- Sun Exposure & Skin Cancer
- Synovial Sarcoma
- Testicular Cancer
- Throat Cancer
- Thrombocytosis
- Thymoma and Thymic Carcinoma
- Thymus Gland Tumor
- Thyroid Cancer
- Tracheobronchial Tumor
- Transitional Cell Cancer
- Urethral Cancer
- Uterine Sarcoma
- Vaginal Cancer
- Vascular Tumor
- Vulvar Cancer
- Wilms Tumor
Could not find what you are looking for?
No worries — just tell us what you need, and our experts will guide you personally.
Best Oncology Doctors in India
Dr. Sujith Mullapally
Consultant
Medical Oncologist
Apollo Proton Cancer Centre, Chennai
Dr. Satya Pal Kataria
Vice Chairman
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Dr. Muzammil Shaikh
Director
Medical Oncologist
Nanavati Super Specialty Hospital, Mumbai
WhatsApp Us
